TELA Bio, Inc. Share-based Payment Arrangement, Decrease for Tax Withholding Obligation
TELA Bio, Inc. (TELA) reported Share-based Payment Arrangement, Decrease for Tax Withholding Obligation of $15.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes
us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-08-11
- TELA Bio, Inc. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2026-06-30 was $15.00K, a 400.00% increase year-over-year.
- TELA Bio, Inc. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2026-03-31 was $79.00K, a 55.37% decline year-over-year.
- TELA Bio, Inc. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2025-12-31 was $4.00K, a 63.64% decline year-over-year.
- TELA Bio, Inc. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2025-09-30 was $21.00K, a 10.53% increase year-over-year.
- TELA Bio, Inc. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2025 was $205.00K, a 44.44% decline from fiscal 2024.
- TELA Bio, Inc. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2024 was $369.00K, a 27.68% increase from fiscal 2023.
- TELA Bio, Inc. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2023 was $289.00K, a 84.08% increase from fiscal 2022.
- TELA Bio, Inc. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2022 was $157.00K.
| Period end | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 3 month | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 6 month | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 9 month | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $15.00K 10-Q · filed 2026-08-11 | $94.00K 10-Q · filed 2026-08-11 | $98.00K derived: sum of 3 quarters · filed 2026-08-11 | $119.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $79.00K 10-Q · filed 2026-05-13 | $83.00K derived: sum of 2 quarters · filed 2026-05-13 | $104.00K derived: sum of 3 quarters · filed 2026-05-13 | $107.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $25.00K derived: sum of 2 quarters · filed 2026-03-25 | $28.00K derived: sum of 3 quarters · filed 2026-08-11 | $205.00K 10-K · filed 2026-03-25 |
| 2025-09-30 | $21.00K 10-Q · filed 2025-11-14 | $24.00K derived: sum of 2 quarters · filed 2026-08-11 | $201.00K 10-Q · filed 2025-11-14 | $212.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $3.00K 10-Q · filed 2026-08-11 | $180.00K 10-Q · filed 2026-08-11 | $191.00K derived: sum of 3 quarters · filed 2026-08-11 | $210.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $177.00K 10-Q · filed 2026-05-13 | $188.00K derived: sum of 2 quarters · filed 2026-05-13 | $207.00K derived: sum of 3 quarters · filed 2026-05-13 | $218.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $30.00K derived: sum of 2 quarters · filed 2026-03-25 | $41.00K derived: sum of 3 quarters · filed 2026-03-25 | $369.00K 10-K · filed 2026-03-25 |
| 2024-09-30 | $19.00K 10-Q · filed 2025-11-14 | $30.00K derived: sum of 2 quarters · filed 2025-11-14 | $358.00K 10-Q · filed 2025-11-14 | $362.00K derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-06-30 | $11.00K 10-Q · filed 2025-08-11 | $339.00K 10-Q · filed 2025-08-11 | $343.00K derived: sum of 3 quarters · filed 2026-03-25 | $348.00K derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-03-31 | $328.00K 10-Q · filed 2025-05-08 | $332.00K derived: sum of 2 quarters · filed 2026-03-25 | $337.00K derived: sum of 3 quarters · filed 2026-03-25 | $338.00K derived: sum of 4 quarters · filed 2026-03-25 |
| 2023-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $9.00K derived: sum of 2 quarters · filed 2026-03-25 | $10.00K derived: sum of 3 quarters · filed 2026-03-25 | $289.00K 10-K · filed 2026-03-25 |
| 2023-09-30 | $5.00K 10-Q · filed 2024-11-08 | $6.00K derived: sum of 2 quarters · filed 2024-11-08 | $285.00K 10-Q · filed 2024-11-08 | $285.00K derived: sum of 4 quarters · filed 2025-03-21 |
| 2023-06-30 | $1.00K 10-Q · filed 2024-08-13 | $280.00K 10-Q · filed 2024-08-13 | $280.00K derived: sum of 3 quarters · filed 2025-03-21 | $284.00K derived: sum of 4 quarters · filed 2025-03-21 |
| 2023-03-31 | $279.00K 10-Q · filed 2024-05-10 | $279.00K derived: sum of 2 quarters · filed 2025-03-21 | $283.00K derived: sum of 3 quarters · filed 2025-03-21 | $283.00K derived: sum of 4 quarters · filed 2025-03-21 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | $4.00K derived: sum of 2 quarters · filed 2025-03-21 | $4.00K derived: sum of 3 quarters · filed 2025-03-21 | $157.00K 10-K · filed 2025-03-21 |
| 2022-09-30 | $4.00K 10-Q · filed 2023-11-13 | $4.00K derived: sum of 2 quarters · filed 2023-11-13 | $157.00K 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $153.00K 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | $153.00K 10-Q · filed 2023-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| InspireMD, Inc. (NSPR) | $0.033B |